Dalbergioidin Ameliorates Doxorubicin-Induced Renal Fibrosis by Suppressing the TGF-β Signal Pathway
The expression of TGF-β in kidney tissue 5 weeks after DXR injection in different groups of mice as indicated. (a) DAL decreases the gene expression of TGF-β; (b) DAL decreases the protein expression of TGF-β by ELISA; (c) DAL decreases the protein expression of TGF-β as determined by western blotting. The control and DAL treatment groups are compared with the DXR group. Values are statistically significant at ; the DXR group is compared with the control group. Values are statistically significant at .